Ophthalmology Times Europe - Latest news in cataract, refractive, retina, glaucoma and more

ADVERTISEMENT

SEARCH
  • home
  • about us
  • contact us
  • subscribe
  • media kit request
 

CATARACT

GLAUCOMA

REFRACTIVE

RETINA

Thursday, 29 July 2010
Seeing Paris
July 28, 2010
Get the most out of your stay in Paris by looking out for OTEurope?s City Guide. We recommend the best restaurants, bars and cafés to visit and the sights not to be missed.
Valproic acid shown to halt vision loss in patients with retinitis pigmentosa
July 28, 2010
Researchers at the University of Massachusetts Medical School (UMMS) believe they may have found a new treatment for retinitis pigmentosa (RP), a severe neurodegenerative disease of the retina that ultimately results in blindness.
Hoya invests in shape-changing, accommodating IOL
July 27, 2010
Hoya has formed a strategic partnership with Adoptics of Switzerland by funding the development of a shape-changing accommodating intraocular lens (AIOL).
Potential of microplasmin for nonsurgical treatment of vitreomacular adhesion
July 21, 2010
Findings published in the July/August edition of Retina contain the results of a Phase II trial indicating that microplasmin was generally well tolerated, and support its potential for nonsurgical resolution of vitreomacular adhesion
European Commission's Scientific Committee is asking for ophthalmic experts' help
July 20, 2010
The European Commission's independent Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) is seeking the assistance of ophthalmic experts who are interested in helping with its Health Effects Of Artificial Light working group.
Tweet!
June 2010
Retina
Dr Patz remembered
By: Jennifer Webb
Glaucoma
First choice for glaucoma
By: Kuldev Singh
Trab-shunt debate
By: David Greenfield, Dale Heuer
Device aids glaucoma testing
By: Sunita Radhakrishnan
Visual field may not show early damage
By: Gabi Wollstein
General
Cornea warming during laser treatment
Oculogenetic highlights include advances in therapy and technology
By: Edwin M Stone
Laser benifits outweigh drawbacks
By: William Culbertson
Cataract & Refractive
Google Health lets patients centralize their history
By: H Jay Winicki
Strong clinical progress in assisted eye examinations
Experience plays role in choice of syringes
By: Johnny Gayton, Alan Crandall
Adjunctive safety tool proves valuable
By: Dan Z Reinstein
Cornea
Keratoconus approach is promising
By: Peter S Hersh
May 2009
Retina
Address diabetic retinopathy by treating underlying disease
By: Mark Abelson, Rad Tzekov, Dayse Sena, Peter Lou, Daniel Dewey-Mattia
Cataract & Refractive
Evaluation of the change in tear osmolarity after using different eye drops
By: Timothy Albert
Pseudophakic monovision vs bilateral multifocal IOLs
By: Alessandro Franchini
Blue-light-filtering lens – theory versus empirical experience?
By: Holger Baatz
Toric IOLs in cataract surgery
By: Jorge L Alio, Jaime Javaloy
Cornea
Cross-linking clinical trail outcomes still favourable
By: R Doyle Stulting
Glaucoma
How a macrodisc may lead to a misdiagnosis of glaucoma
By: Christoph Faschinger
Research explores why ageing predisposes the eye to glaucoma
By: Jonathan G Crowston, George Kong
Neuroprotective agent in sight?
By: Stuart J McKinnon
Ophthalmology Times Europe is the independent source for current developments and best practices in European Ophthalmology. It is the balanced and unbiased forum for ophthalmologists to communicate practical experience, clinical knowledge, discoveries and applications, thereby promoting improvements in medical medical practice and patient health.
Serving Europe's ophthalmic community
Make This Page Your Home Page!
Blue laser autofluorescence
Survey
In the management of glaucoma which is your preference?
Preservative prostaglandin
Preservative-free prostaglandin
Preservative prostaglandin
29%
Preservative-free prostaglandin
71%
View Results
Thank you for voting.
Newsletter sign-up

ADVERTISEMENT

Click here